Platelet-Rich Plasma by Single-Spin Process in Male Pattern Androgenetic Alopecia: Is It an Effective Treatment?

January 2017 in “ Indian Dermatology Online Journal ”

Arshdeep

platelet-rich plasma PRP single-spin process double-spin method male pattern androgenetic alopecia hair density hair thickness hair restoration

Studysummary This commentary reviews clinical trials on platelet-rich plasma treatments for androgenetic alopecia and emphasizes the need for standardized preparation methods and concentrations; it reports no new clinical results.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The study investigated the effectiveness of platelet-rich plasma (PRP) prepared by a single-spin process in treating male pattern androgenetic alopecia. The results indicated that PRP treatment led to a significant increase in hair density and thickness in the 50 male participants, suggesting PRP could be a promising treatment option for male pattern hair loss. However, the commentary noted that the single-spin method often failed to achieve the ideal platelet concentration of ≥1 million platelets/μl, unlike the double-spin method, which produced better clinical outcomes. It emphasized the need for standardized PRP preparation methods and further clinical trials to validate PRP's efficacy in hair restoration.

View this study on journals.lww.com →

Discuss this study in the Community →

Research cited in this study

7 / 7 results

research Platelet-Rich Plasma for Treatment of Non-Scarring Hair Loss: Systematic Review of Literature

25 citations , March 2017 in “Journal of Dermatological Treatment”

This review found that the current evidence on using platelet rich plasma to treat non-cicatricial alopecia, such as androgenetic alopecia and alopecia areata, is of low quality and yields controversial results.

research The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study

70 citations , February 2017 in “Dermatologic Surgery”

This study reports that plasma rich in growth factors appeared to improve hair follicle regeneration and patient satisfaction in individuals with androgenetic alopecia, though further trials are needed.

research Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia

87 citations , September 2016 in “Dermatologic Surgery”

This study found that platelet-rich plasma did not significantly improve hair mass index or hair count in women with female androgenetic alopecia, though some patients perceived benefits in hair quality.

research Platelet-Rich Plasma for Androgenetic Alopecia

107 citations , August 2014 in “Dermatologic Surgery”

This pilot study suggests injecting platelet-derived growth factors into the scalp may offer some clinical benefits for androgenetic alopecia, though further randomized trials are needed for confirmation.

research Platelet-Rich Plasma in Dermatology: Boon or Bane?

119 citations , January 2014 in “Indian Journal of Dermatology, Venereology and Leprology”

This review discusses the use of platelet-rich plasma in various dermatological applications and reports no new clinical results; the authors call for more rigorous trials to confirm its effectiveness.

research Study of Platelet-Rich Plasma Injections in the Treatment of Androgenetic Alopecia Through a One-Year Period

164 citations , January 2014 in “Journal of Cutaneous and Aesthetic Surgery”

This study found that PRP injections may improve hair density and reduce hair loss in patients with androgenetic alopecia without significant side effects, but further research is needed to confirm efficacy.

research Autologous Platelet-Rich Plasma: A Potential Therapeutic Tool for Promoting Hair Growth

270 citations , March 2012 in “Dermatologic Surgery”

This study found that autologous platelet-rich plasma increased hair growth potential by enhancing dermal papilla cell proliferation and stimulating key signaling pathways in both cell cultures and mice models.